White Paper

Going Paperless From Lab To Plant

Many leading life sciences companies have introduced cost-reduction initiatives to automate routine, non-value-added tasks related to data capture, cataloguing and documentation activities as products move from discovery through development to late-stage quality control, manufacturing and commercial operations. In most regulated companies, the key documentation needs in discovery and early development tend to be related to intellectual property (IP) protection, while approximately 70% of laboratory resources from later development through commercialization are focused on meeting compliance requirements.

Within the lab-to-commercialization process, the drive to “go paperless” is a strategic initiative that offers demonstrable operational benefits in improving productivity, reducing cycle times and enabling organizations to leverage experimental and operational data generated along the entire research-development-manufacturing continuum. For example, quality and pilot plant data generated during late-stage commercialization can accelerate early product, process and analytical method development by enabling better Quality by Design (QbD) experiments that are based on real-world conditions, experience and insight. Likewise, the proper management and exchange of process and product design, execution and documentation creates enterprise-wide intelligence that accelerates product commercialization cycle times.

An electronic environment drives improved “Scientific Innovation Lifecycle Management” by enabling the automation of critical processes and data harmonization across research, development and manufacturing/quality environments. This functional capability is facilitated by the Accelrys Enterprise Platform, a scientifically aware informatics platform that integrates critical lab-enabling software functionality with existing enterprise systems and information sources and enables organizations to deploy scientific software and services solutions along the end-to-end, lab-to-plant lifecycle—speeding “science to compliance” for organizations that rely on scientific innovation to differentiate themselves.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma